Lowell Anthony joined the UK Markey Cancer Center with more than two decades of experience in oncology and a special focus in gastrointestinal and neuroendocrine oncology. His clinical interests include drug development ranging from Phase I to III clinical trials. Agents targeting specific cellular signaling pathways and injectable radiolabeled compounds make up his past and current clinical investigative interests. He brings a clinical correlative component to complement the ongoing translational activities at Markey Cancer Center.

Dr. Anthony attended Vanderbilt University Medical School, where he also completed a medical residency and fellowship training in medical oncology and clinical pharmacology. He has previously been on the medical faculties at Vanderbilt University and the Louisiana State University Health Sciences Center in New Orleans.

Personal Statement

It takes a village to treat cancer, so when the patient is initially evaluated at Markey Cancer Center, a care plan is developed across specialties. So it's more encompassing than just a single visit to one specialist who treats cancer. Right now in oncology, the most exciting development is immunotherapy. Our challenge is to find out how we integrate this into other forms of how we treat cancer; both from other medicine, other drugs and potentially other modalities such as radiation.

Faculty Rank